Signal active
Investment Firm
Overview
Millennium Management is an investment management company. They seek an array of investment strategies across industry sectors, asset classes, and geographies. Their entrepreneurial environment enables them to manage their investment processes. They also seek to accelerate by providing sophisticated resources and technology.
Highlights
1989
Financial Services
5001-10000
15
1
7
Early Stage Venture, Late Stage Venture, Private Equity
Hedge Fund
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
Millennium Management, established in 1989 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Late Stage Venture, Private Equity investments across Biotechnology, Health Care, Pharmaceutical, Medical, Financial Services, Finance, Photography, Asset Management, Wealth Management, Retirement. The organization boasts a portfolio of 14 investments, with an average round size of $257.2M and 7 successful exits. Their recent investments include Cardurion Pharmaceuticals, Farallon Capital Management, Fidelity, New Enterprise Associates, Google Ventures. The highest investment round they participated in was $547.7B. Among their most notable exits are Cardurion Pharmaceuticals and Farallon Capital Management. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
15
2
1
7
Investments
15
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jan 25, 2022 | Metagenomi | Biotechnology | 175.0M |
Nov 17, 2022 | One97 Communications | Information Technology | 200.0M |
May 25, 2023 | Carmot Therapeutics | Biotechnology | 150.0M |
Jul 16, 2024 | Cardurion Pharmaceuticals | Biotechnology | 260.0M |
Exits
7
Funding Timeline
15
0
0
Funding Rounds
15
Millennium Management has raised 15 rounds. Their latest funding was raised on Jul 16, 2024 from a Series B - Cardurion Pharmaceuticals round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jan 25, 2022 | Series B - Metagenomi | - | 175.0M | - |
Nov 17, 2022 | Post-IPO Secondary - One97 Communications | - | 200.0M | - |
May 25, 2023 | Series E - Carmot Therapeutics | - | 150.0M | - |
Jul 16, 2024 | Series B - Cardurion Pharmaceuticals | - | 260.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.